INZEN
Live / Registered — Registered (as of 14 Jan 2020)
What this means for you
Registered since 14 Jan 2020. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 88052072
- Registration number
- 5962468
- Mark type
- Stylized text
- Filed
- 25 Jul 2018
- Published for opposition
- 26 Mar 2019
- Registered
- 14 Jan 2020
- Attorney of record
- Christina M. Licursi
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical agents and products for cellular signal modulation for treating cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; therapeutic products for cellular signal modulation in the nature of chemical and biological small molecules; pharmaceutical compositions in the nature of chemical and biological small molecules for treatment of cancer, fibrotic diseases, immune and inflammatory diseases, neurological diseases, infectious disease, tissue degenerative diseases, regenerative medicine; pharmaceutical compositions in the nature of chemical and biological molecules for cellular signal modulation
- Class 042 — Scientific and technological services: Scientific research, pharmaceutical research, and medical research in the fields of pharmaceutical research and development and biotechnology for others; product development for others in the field of biotechnology; development of pharmaceuticals and therapeutic agents for others
Owner
- INZEN THERAPEUTICS, INC., CAMBRIDGE, MA, US
- VL47, Inc., Cambridge, MA, US
- VL47, Inc., Cambridge, MA, US
- VL47, Inc., Cambridge, MA, US
Prosecution history
- 14 Jan 2025 — COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
- 11 Nov 2020 — AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
- 14 Jan 2020 — REGISTERED-PRINCIPAL REGISTER
- 10 Dec 2019 — NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
- 08 Dec 2019 — ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
- 30 Nov 2019 — STATEMENT OF USE PROCESSING COMPLETE
- 21 Nov 2019 — USE AMENDMENT FILED
- 30 Nov 2019 — CASE ASSIGNED TO INTENT TO USE PARALEGAL
- 21 Nov 2019 — TEAS STATEMENT OF USE RECEIVED
- 21 May 2019 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 26 Mar 2019 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 26 Mar 2019 — PUBLISHED FOR OPPOSITION
- 06 Mar 2019 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 20 Feb 2019 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 04 Feb 2019 — TEAS/EMAIL CORRESPONDENCE ENTERED